Advertisement
<< Back To Article
More Treatment, Less PrEP Would Slash New HIV Cases by 94%

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

2 Comments

Rupi3000

The actual issue is that we have to calculate with $12,599 annual cost for prep. That’s obscene profiteering by pharma companies and others in the ‘value’ chain. You can source Truvada for less than $20 for a 30 pill supply (see cost plus drugs - US manufacturer of generics, they mark up production cost by 15% and sell it for that price) which amounts to $240 per year or about 2% of what you’d pay through the ‘health care’ system.

February 24, 2023

Tom CRAIG

Well the question is are we really going to start a fight over allocations to end new HIV transmissions because of lower funding allocations? I hope not. PrEP has been shown in many lab studies to effectively reduce new HIV infections and to bring into the health system person not really destined to go see a doctor before for prevention. Which everyone benefits from. The problem with this study's idea to re-allocate funding to TASP and testing is not a good idea.

January 26, 2021 Paris, France


Hot topics


Tu Salud uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Tu Salud uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.